Board meetings, strategic plans, and buyer signals from Janice Beller’s organization
Jun 4, 2026·BoardMeeting
Board
Board of Pharmacy Board Meeting Minutes
The Board meeting covered a comprehensive agenda including training on open meeting laws, a financial update for the third quarter of fiscal year 2026, and an extensive review of the 2026 legislative session regarding various pharmacy-related bills. Key operational discussions included a presentation on university recruitment and enrollment, updates to the Prescription Drug Monitoring Program delegated authority, and the approval of new risk-based inspection criteria and standard operating procedures to improve facility assessment consistency. Additionally, the Board conducted elections for Chair and Vice-Chair, held an executive session to discuss draft legislation and disciplinary matters, and acted on several licensee disciplinary cases and application reviews.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
The board reviewed the second-quarter financial report and discussed legislative updates, including various house and senate bills. The meeting included annual respectful workplace training, an update on the Interprofessional Advisory Committee on Lifestyle Injectables, and progress on risk-based inspections. The board discussed upcoming conference attendance and delegate appointments for the NABP Annual Meeting, reviewed NABP resolutions, and discussed the December meeting date change. Additionally, the board reviewed chiropractic prescriptive authority, discussed a received public comment, entered executive session to consider licensee records, approved an application, and issued letters of concern for several disciplinary cases.
Dec 11, 2025·BoardMeeting
Board
Board of Pharmacy Board Meeting Minutes
The Board of Pharmacy meeting addressed several key operational and regulatory matters. A financial report for the first quarter of the fiscal year was presented, noting progress toward target cash balance goals. An update was provided on the transition of facility licenses to a two-year renewal cycle, with project completion expected by 2028. The Board received training on Open Meeting Law and reviewed draft language for the Controlled Substance Act, including scheduling updates. Additionally, policies regarding Schedule II prescription changes were reviewed and approved. A shift from an annual inspection cycle to a triennial, risk-based inspection process was proposed and approved. The meeting also included an annual review of delegated authority policies and discussions on upcoming conference attendance, followed by public commentary from the Idaho State University College of Pharmacy.
Sep 18, 2025·BoardMeeting
Board
Board Of Pharmacy Board Meeting Minutes
The Board meeting included a financial update regarding the fourth quarter of the fiscal year and the strategic plan for managing the cash balance. Discussions were held regarding the Health Professions Recovery Program, proposed amendments to the Controlled Substances Act, an update on the Medications for Opioid Use Disorder grant, and statistics for the Prescription Drug Monitoring Program. Additionally, the Board reviewed and approved several policy updates, discussed conference attendance, received an accreditation update from the Idaho State University College of Pharmacy, entered an executive session to address licensee matters, and took action on various applications and disciplinary cases.
Extracted from official board minutes, strategic plans, and video transcripts.
